-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Efferocytosis is the phagocytosis of apoptotic cells by specialized phagocytes (such as macrophages) and non-specialized phagocytic cells (such as epithelial cells), which participates in tissue repair and homeostasis
Efferocytosis is the phagocytosis of apoptotic cells by specialized phagocytes (such as macrophages) and non-specialized phagocytic cells (such as epithelial cells), which participates in tissue repair and homeostasis
Efferocytosis can maintain the steady state in biological evolution
Efferocytosis can maintain the steady state in biological evolution
Previous studies have demonstrated the key role of endocytosis in the development of atherosclerosis and the regulatory effect of endocytosis on atherosclerosis
Previous studies have demonstrated the key role of endocytosis in the development of atherosclerosis and the regulatory effect of endocytosis on atherosclerosis
In NASH treatment, there are several natural products that can regulate the activation, recruitment and polarization of macrophages to reduce inflammation, reduce lipid accumulation and improve insulin sensitivity , such as sparstolonin B, berberine and celastrol
There are also several natural products that can regulate the activation, recruitment and polarization of macrophages to reduce inflammation, reduce lipid accumulation and improve insulin sensitivity
Natural products have fewer adverse reactions and multi-target characteristics, and are potential pharmaceutical ingredients for the treatment of multi-system diseases in the future
Natural products have fewer adverse reactions and multi-target characteristics, and are potential pharmaceutical ingredients for the treatment of multi-system diseases in the future
Original: Zhang Y, Wang Y, Ding J, Liu P.
Leave a message here